Introduction
Matrix Gla-protein (MGP) is a vitamin K-dependent protein acting as a potent inhibitor of soft tissue calcification, mainly in the vessel wall and cartilage [1] . During its synthesis MGP undergoes extensive posttranslational modification, i.e. serine phosphorylation and glutamate carboxylation (to form Gla). Vascular vitamin K insufficiency is associated with the production of desphospho-uncarboxylated MGP (dp-ucMGP), which has no calcification inhibitory activity and which is set free in the circulation, where it can be quantified by assays based on the sandwich ELISA principle. Most data presently available in the literature are based on a handmade microtiter plate assay designed at VitaK laboratories [2] . Here we present a fully automated version of the same assay, which is produced by IDS: the InaKtif MGP assay.
Antibodies used:
Monoclonal antibodies against the phosphoserine domain (aa 3-15) and the Gla-domain (aa 35-49) in human MGP. Assay principle: The IDS Automated Analyser IDS-iSYS InaKtif MGP assay uses both highly specific monoclonal antibodies. One biotinylated antibody is coupled to magnetic particles (MP). The second antibody is coupled to an acridinium ester derivative. 50 µl of sample is incubated with 20 µL of MP and the second antibody. After 60 min of incubation, followed by a washing step, triggers are added whereby the luminescence measured is directly proportional to the InaKtif MGP concentration present in the sample. The time to first result is 63 minutes. The throughput of the assay is 89 tests/hour. Assay Diagram: 
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Sensitivity: Sensitivities LOB, LOD and LOQ were evaluated in accordance with CLSI EP17-A Guideline. LOB and LOD were determined respectively at 47 and 119 pM. Precision: Precision was evaluated according to CLSI EP-5A Guideline. Five control plasma samples were assayed in duplicate twice a day for a minimum of 20 days. Table 3 

The automated dp-ucMGP assay closely resembles the microtiter plate version. Therefore, data obtained with both assays are comparable.  The InaKtif MGP assay provides a quantitative measure for the vitamin K status of the vessel wall.  Poor vascular vitamin K status was demonstrated to be a major risk factor for cardiovascular morbidity and mortality, both in patients and in the healthy population  Studies in which cardiovascular end points are monitored should be stratified for dpucMGP.  Poor vitamin K status is a modifiable risk factor for arterial calcification, and the InaKtif MGP assay is the most direct way to identify patients at risk and to monitor the effect of vitamin K supplementation.
Linearity:
The linearity was realized according to the EP-6A CLSI recommendation. The IDS-iSYS InaKtif MGP assay shows a good linearity over the dynamic range (figure 2).
Recovery: 3 serum samples were spiked with 2 different amounts of known MGP concentration. The recovery was determined by comparing recovered concentrations to the added concentrations. Data are shown in table 3.
Vitamin K status
The microtiter plate assay and the InaKtif MGP assay were measured in volunteers before and after vitamin K supplementation, and in patients on vitamin K antagonist treatment (figure 3).
Conclusions
